Free Shipping Within the US
Money Back Guarantee

Cannabielsoin acid A (CBEA-A)

Dale blog imageAuthor: Dale Hewett
Table of Contents (Scrollable)

Cannabielsoin Acid A (CBEA-A) is a compound obtained from the cannabis or marijuana plant. CBEA is a derivative of the Cannabigerovarinic Acid (CBGVA) which can be further broken down through the process of oxidization to give cannabielsoin (CBE). 

CBEA-A being one of the discoveries since 1940 when British chemist Robert S. Cahn reported the partial structure of cannabinol (CBN).

During research into the cannabis plant, CBEA-A was discovered alongside other compounds of CBD, CBC, CBG, CBN, and other compounds discovered during that research. The group of researchers isolated the compound from Hashish, a resin from an active flowering marijuana plant. 

The compound is formed through a series of transformations during the cannabis plant blooming stage. CBEA-A evolved from the precursor, cannabigerovarinic acid (CBGVA), which is also described by scientists as the mother of all cannabinoids.

Formed from CBGVA using manganese in the presence of air, it is synthesized by oxidative cyclization.

Related: What is CBN?

A molecule of CBEA-A contains multiple bonds, membered rings, hydroxyl groups, aromatic hydroxyl, non-H bonds, rotatable bonds, carboxylic acid, alcohol. Its structure involves atoms arrangement and bonds that keep atoms solidly fixed together. 

The interest in CBEA-A arose from the chemical composition and positioning of its power cells. CBEA-A and other compounds of such variations are still yet to be looked into, but much is expected on a futuristic look.

Researchers are looking to unlocking more functions of the cannabis plants asides its psychoactive or therapeutic ability, and hopes are on CBEA-A to being that key.


Asides the chemical composition and structure of this compound, there is still no test as at this time to show or prove the functional characteristic and features of CBEA-A.

Related: CBD vs CBN

Since the carbons are present at the corners, researchers are hoping to explore what this means and how this will translate into functionality regarding its therapeutic benefits and if it will act in the same line as THC, CBD, CBN, and other well-identified cannabis compounds.


Unlike THC, CBD, CBN, whose therapeutic function results have been ably solidified to a certain degree, researchers know nothing of what CBEA-A can do.

There are no tests or clinical trials to tell what its therapeutic possibilities or potentials can be. Medical practitioners, despite the little information we have on the cannabis plant and its compounds, have speculated a very much beneficial use of and for the plants to treating medical diseases and cases.

The conclusive logical corollary here is, CBEA-A is expected to have some benefits of its own.  


  • It contains a total of 59 molecule bonds.
  • It is one of the few strains with multiple compounds in its chemical structure.
  • 22H30O5, it has a mass of 374.4706 g/mol.
  • It may also be produced by photooxidation from CBDA.
  • CBEA-A appears to be infrequently identified in natural sources

Cbd Products For Sale


National Center for Biotechnology Information. “PubChem Compound Summary for CID 162113, Cannabielsoin” PubChem,

Aizpurua-Olaizola O, Soydaner U, Öztürk E, Schibano D, Simsir Y, Navarro P, Etxebarria N, Usobiaga A (February 2016). “Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes”. Journal of Natural Products. 79 (2): 324–31. doi:10.1021/acs.jnatprod.5b0094

blog BG
Table of Contents

Search our website for more information on CBD:

Related Cannabinoids

Commitment to Trusted Information on CBD

When it comes to understanding both the science and benefits of cannabidiol (CBD), it is extremely important that you can trust the source of your information. This is exactly why our team at New Phase Blends includes experts in the field of cannabinoid research and development, including frequent correspondence with certified medical professionals and PhDs in relevant fields via studies, research, and additional peer reviewed pieces of information. All information published is reviewed and checked for accuracy. We pride ourselves on staying up-to-date with the latest scientific research and clinical studies related to not only CBD, but also its effects on the human body.

Our website also includes an About Us page, where you can learn more about our team, mission, and commitment to providing accurate, reliable information about CBD. Users can access this from the header menu at the top of the screen. Additionally, all of our products are third-party lab tested for quality and purity, and we make the results of these tests easily accessible to our customers.

User Experience Strengthened Through The Use of AI Content

Some articles you read may contain content created by the use of AI tools. This content is always edited by a human. We fact check any AI content, and ensure the information produced is accurate, up to date, and relevant to the article it may be contained in. All content is verified against peer reviewed data on CBD written by PhD’s and respective experts in their field of medical science.

Our goal in using AI content is to increase the user experience by increasing content production, and quality. This results in more information becoming available to the reader more frequently.

About the Author - CBD Expert Dale Hewett

Dale Hewett Author
Dale Hewett

Dale Hewett is the owner and founder of New Phase Blends. He discovered his passion for CBD use after suffering from injuries sustained while on Active Duty in the US Army. His number one priority is introducing the same CBD products that he himself uses for relief to others who can benefit from them.

Dale holds a Master Degree of Science, and is the inventor of the popular, CBD-based sleep aid known as ‘Sleep.’ He’s given multiple lectures on CBD to institutions such as Cornell’s MBA student program, and Wharton’s School of Business.

la wire logo
yahoo finance greyscale
forbes logo
Markets Insider Logo
chicago journal logo greyscale